Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5

Eosinophilia syndromes are heterogenous disorders possessing different clinical manifestations characterized by peripheral blood eosinophilia and end organ damage. Treatment includes glucocorticoids, hydroxyurea (hydroxycarbamide), chemotherapy and interferon-α. Recently, an explanation for the eosi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Expert review of clinical immunology 2005-11, Vol.1 (4), p.633-644
Hauptverfasser:	Stein, Miguel L, Rothenberg, Marc E
Format:	Artikel
Sprache:	eng
Schlagworte:	anti-IL-5 anti-interleukin-5 Biological products Biological response modifiers Cell activation Corticosteroids eosinophilia FIP1L1-PDGFRA Health aspects hyepereosinophilic syndromes IL-5 imatinib Interferon interleukin-5 Interleukins Platelet-derived growth factor T cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!